Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Zaher A. Radi"'
Autor:
Zaher A. Radi, Robert Ostroski
Publikováno v:
Mediators of Inflammation, Vol 2007 (2007)
Hypertensive mice that express the human renin and angiotensinogen genes are used as a model for human hypertension because they develop hypertension secondary to increased renin-angiotensin system activity. Our study investigated the cellul
Externí odkaz:
https://doaj.org/article/1a612f6896dd4099835f2e7524b42757
Publikováno v:
Intestinal Research, Vol 21, Iss 3, Pp 295-305 (2023)
Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a lifelong disease that manifests with chronic intestinal inflammation, sequential fibrosis, and an increased risk of colitis-associated colon cancer (CAC). The
Externí odkaz:
https://doaj.org/article/6eb8bf4bc7784d7792a7758a7a436b61
Autor:
Zaher A. Radi, Yurong Lai
Publikováno v:
Current Opinion in Toxicology. 29:65-69
Autor:
Zaher A. Radi, Nasir Khan
Publikováno v:
Toxicology and Applied Pharmacology. 466:116471
Autor:
Zaher A. Radi, Thomas A. Wynn
Publikováno v:
Toxicologic Pathology. 48:712-717
Immune tolerance is defined by an active state of immune system unresponsiveness to foreign and self-antigens. Loss of immune tolerance to self-antigens and the resulting overexpression of autoantibodies can lead to tissue injury and development of v
Autor:
Zaher A. Radi
Publikováno v:
Toxicologic Pathology. 48:721-724
Influx and efflux kidney tubular transporters are major determinants of the disposition of xenobiotics, including pharmaceutical drugs. On the basolateral membrane of proximal tubular cells, there are influx transporters, such as organic cation trans
Publikováno v:
Drug Metabolism and Disposition. 47:802-808
Limited understanding of species differences in kidney transporters is a critical knowledge gap for prediction of drug-induced acute kidney injury, drug interaction, and pharmacokinetics in humans. Here, we report protein abundance data of 19 transpo
Autor:
Zaher A. Radi, Gary Seitis, Yutian Zhan, Maria Engel, Stephanie L. Coffing, Katherine Hales, Maik Schuler, Lindsay Tomlinson, Saurabh G. Vispute, Jon C. Cook, Brett D. Hollingshead, Jennifer R. Cheung, Michael Homiski, Elizabeth Rubitski, Andrew Robertson
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 180(1)
Risk management of in vitro aneugens for topically applied compounds is not clearly defined because there is no validated methodology to accurately measure compound concentration in proliferating stratum basale keratinocytes of the skin. Here, we exp
Autor:
Jim Finley, Lindsay Tomlinson, Sarah P. Nicholson, Stacey R. Oppenheimer, Jessica L. Moore, Maik Schuler, Nathan Heath Patterson, Kevin Beaumont, Brett D. Hollingshead, Zaher A. Radi, Colleen M. Doshna, Casey Ritenour, Richard M. Caprioli, Shawn P. O'Neil, Jon C. Cook, Jason Barricklow, Amanda King-Ahmad, Saurabh G. Vispute, Jeremy L. Norris
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 123
Systemic toxicity assessments for oral or parenteral drugs often utilize the concentration of drug in plasma to enable safety margin calculations for human risk assessment. For topical drugs, there is no standard method for measuring drug concentrati
Autor:
W. Mark Vogel, Douglas J. Ball, Mark Collinge, Zaher A. Radi, Andrea L. Nilson, Christopher J. Bowman
Publikováno v:
Regulatory Toxicology and Pharmacology. 94:306-322
Tofacitinib, an oral Janus kinase (JAK) inhibitor for treatment of rheumatoid arthritis, targets JAK1, JAK3, and to a lesser extent JAK2 and TYK2. JAK1/3 inhibition impairs gamma common chain cytokine receptor signaling, important in lymphocyte devel